NCT04921631

Brief Summary

The National Academy of Medicine and the National Institutes of Health have called for urgent action to improve the care delivered to the nearly 1,000,000 older Americans who die in intensive care units (ICUs) annually, or survive with substantial impairments. These patients often die with distressing symptoms and may receive more invasive, life-prolonging treatment than they would choose for themselves. Moreover, their family members acting as surrogate decision makers often experience lasting psychological distress from the ICU experience. The investigators will conduct a randomized trial among 500 patients and 750 surrogates and up to 150 clinicians to determine whether early integration of specialty palliative care with standard critical care can improve outcomes for critically ill older patients at high risk of death or severe functional impairments and their family members.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,091

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 28, 2021

Completed
13 days until next milestone

First Posted

Study publicly available on registry

June 10, 2021

Completed
18 days until next milestone

Study Start

First participant enrolled

June 28, 2021

Completed
4.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2026

Completed
Last Updated

May 1, 2026

Status Verified

April 1, 2026

Enrollment Period

4.7 years

First QC Date

May 28, 2021

Last Update Submit

April 27, 2026

Conditions

Keywords

Intensive carePalliative careSurrogate decision-makingQuality of communicationPatient-centered careAnxietyDepressionPost-traumatic stress disorder

Outcome Measures

Primary Outcomes (1)

  • Patient and family centeredness of care

    12-item Patient Perceived Patient-Centeredness of Care Scale (PPPC), previously modified for use by surrogates, completed at 3-month telephone follow-up of surrogates.

    Measured at 3 months after hospital discharge

Secondary Outcomes (14)

  • Composite measure of goal-concordant care

    Measured at 3 months

  • Unmet palliative care needs

    Measured at day 5 post-randomization

  • Surrogates' prognostic awareness

    Measured on study day 5

  • Surrogates' clarity about patient values and preferences

    Measured on study day 5

  • Satisfaction with ICU care

    Measured at 3 months

  • +9 more secondary outcomes

Other Outcomes (4)

  • Patient hospital survival

    Measured at 6 months

  • Duration of survival from hospital discharge through 6-month follow-up

    Measured at 6 months

  • Days alive outside healthcare facilities

    Measured at 6 months

  • +1 more other outcomes

Study Arms (2)

Intervention

EXPERIMENTAL

The intervention arm will receive early specialty palliative care integrated with standard critical care.

Behavioral: Early Integration of Specialty Palliative Care with Critical Care

No intervention

NO INTERVENTION

Usual ICU care; each study ICU has a policy for family meetings within 72 hours of admission and at least weekly thereafter.

Interventions

The PC team will visit the patient within 24 hours of randomization and the consultation will address the following domains of PC: illness understanding and goals of care conversations with patients/surrogates; symptom assessment and management; spiritual needs; patient and family coping and support; and care coordination and transitions. The initial family meeting will be scheduled to occur within two days of randomization. Follow-up visits will be conducted by the PC MD/APP every weekday. During this time, the ICU and PC team will be in daily communication. The PC team will continue to follow the patient in the hospital once discharged from ICU. Prior to discharge, the PC team will document patient goals and preferences for future treatment, coordinate appropriate PC services in the home and/or outpatient clinic settings and contact the patient's primary physician to provide an update on the patient's hospital stay.

Intervention

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Admitted to a participating study ICU
  • Age greater than or equal to 60 years
  • Meets one or more of the following acute or chronic triggers for PC consultation
  • Acute:
  • Cardiac or respiratory arrest with coma
  • Ischemic or hemorrhagic stroke requiring mechanical ventilation
  • ICU admission after hospital stay of greater than or equal to 10 days or ICU readmission within 30 days
  • Age greater than or equal to 80 and 1 or more forms of organ support
  • Multiorgan system failure
  • CCM physician judgment of greater than or equal to 50% risk of in-hospital death or new severe long term functional impairment
  • Chronic:
  • Admission from a SNF or LTACH with progressive functional decline
  • Metastatic (stage IV) cancer or advanced cancer without curative treatment
  • End stage cardiorespiratory disease
  • End stage liver disease
  • +20 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Pittsburgh

Pittsburgh, Pennsylvania, 15213, United States

Location

Related Publications (3)

  • Teno JM, Clarridge B, Casey V, Edgman-Levitan S, Fowler J. Validation of Toolkit After-Death Bereaved Family Member Interview. J Pain Symptom Manage. 2001 Sep;22(3):752-8. doi: 10.1016/s0885-3924(01)00331-1.

    PMID: 11532588BACKGROUND
  • Glass DP, Wang SE, Minardi PM, Kanter MH. Concordance of End-of-Life Care With End-of-Life Wishes in an Integrated Health Care System. JAMA Netw Open. 2021 Apr 1;4(4):e213053. doi: 10.1001/jamanetworkopen.2021.3053.

    PMID: 33822069BACKGROUND
  • Andersen SK, Vincent G, Butler RA, Brown EHP, Maloney D, Khalid S, Oanesa R, Yun J, Pidro C, Davis VN, Resick J, Richardson A, Rak K, Barnes J, Bezak KB, Thurston A, Reitschuler-Cross E, King LA, Barbash I, Al-Khafaji A, Brant E, Bishop J, McComb J, Chang CH, Seaman J, Temel JS, Angus DC, Arnold R, Schenker Y, White DB. ProPACC: Protocol for a Trial of Integrated Specialty Palliative Care for Critically Ill Older Adults. J Pain Symptom Manage. 2022 Jun;63(6):e601-e610. doi: 10.1016/j.jpainsymman.2022.02.344.

MeSH Terms

Conditions

Critical IllnessAnxiety DisordersDepressionStress Disorders, Post-Traumatic

Interventions

Critical Care

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsMental DisordersBehavioral SymptomsBehaviorStress Disorders, TraumaticTrauma and Stressor Related Disorders

Intervention Hierarchy (Ancestors)

Patient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Douglas B White, MD, MAS

    University of Pittsburgh

    PRINCIPAL INVESTIGATOR
  • Yael Schenker, MD, MAS, FAAHPM

    University of Pittsburgh

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

May 28, 2021

First Posted

June 10, 2021

Study Start

June 28, 2021

Primary Completion

February 28, 2026

Study Completion

February 28, 2026

Last Updated

May 1, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will share

Raw data and derived datasets will be made available to external investigators and the public on a case-by-case basis, to be approved by the PI and in accordance with institutional, HIPAA, state and federal regulations. A data-sharing agreement may be instituted, depending upon the data to be shared. All data that is shared will be de-identified to protect participant privacy and confidentiality. Data and datasets will be retained and available to share for at least three years following completion of the project, in accordance with NIH regulations.

Locations